Assembly Biosciences, Inc. (ASMB)

34.07 -2.10% (-0.73)

Over 1M: +35.7%

2026-08-28
25 30 35
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Q3 '21 — Revenue: 6.3M Q3 '21 — Operating Cash Flow: -18.9M Q3 '21 — Free Cash Flow: -18.9M Q3 '21 — Net Income: -18.8M Q4 '21 — Revenue: 0 Q4 '21 — Operating Cash Flow: -19.4M Q4 '21 — Free Cash Flow: -19.4M Q4 '21 — Net Income: -60.3M Q1 '22 — Operating Cash Flow: -27.5M Q1 '22 — Free Cash Flow: -27.5M Q1 '22 — Net Income: -23.1M Q2 '22 — Operating Cash Flow: -17.9M Q2 '22 — Free Cash Flow: -17.9M Q2 '22 — Net Income: -24.5M Q3 '22 — Operating Cash Flow: -19.8M Q3 '22 — Free Cash Flow: -19.9M Q3 '22 — Net Income: -23.1M Q4 '22 — Operating Cash Flow: -19.3M Q4 '22 — Free Cash Flow: -19.3M Q4 '22 — Net Income: -22.4M Q1 '23 — Revenue: 0 Q1 '23 — Operating Cash Flow: -23.4M Q1 '23 — Free Cash Flow: -23.4M Q1 '23 — Net Income: -18.9M Q2 '23 — Revenue: 0 Q2 '23 — Operating Cash Flow: -13.6M Q2 '23 — Free Cash Flow: -13.7M Q2 '23 — Net Income: -16.9M Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -13.8M Q3 '23 — Free Cash Flow: -14M Q3 '23 — Net Income: -14.4M Q4 '23 — Revenue: 7.2M Q4 '23 — Net Income: -11M Q1 '24 — Revenue: 5.8M Q1 '24 — Operating Cash Flow: -18.4M Q1 '24 — Free Cash Flow: -18.4M Q1 '24 — Net Income: -9.1M Q2 '24 — Revenue: 8.5M Q2 '24 — Operating Cash Flow: -17.1M Q2 '24 — Free Cash Flow: -17.1M Q2 '24 — Net Income: -11.2M Q3 '24 — Revenue: 6.8M Q3 '24 — Operating Cash Flow: -15.2M Q3 '24 — Free Cash Flow: -15.2M Q3 '24 — Net Income: -9.6M Q4 '24 — Revenue: 7.4M Q4 '24 — Operating Cash Flow: -407K Q4 '24 — Free Cash Flow: -407K Q4 '24 — Net Income: -10.3M Q1 '25 — Revenue: 9.4M Q1 '25 — Operating Cash Flow: -23.4M Q1 '25 — Free Cash Flow: -23.4M Q1 '25 — Net Income: -8.8M Q2 '25 — Revenue: 9.6M Q2 '25 — Operating Cash Flow: -16.8M Q2 '25 — Free Cash Flow: -16.8M Q2 '25 — Net Income: -10.2M Q3 '25 — Revenue: 10.8M Q3 '25 — Operating Cash Flow: -15.1M Q3 '25 — Free Cash Flow: -15.2M Q3 '25 — Net Income: -9.2M Q4 '25 — Operating Cash Flow: 14.2M Q4 '25 — Free Cash Flow: 14.2M Q4 '25 — Net Income: 22.1M Q1 '26 — Revenue: 8.2M Q1 '26 — Operating Cash Flow: -22.1M Q1 '26 — Free Cash Flow: -22.1M Q1 '26 — Net Income: -9.1M Q2 '26 — Revenue: 13.4M Q2 '26 — Operating Cash Flow: -15.5M Q2 '26 — Free Cash Flow: -15.5M Q2 '26 — Net Income: -3.9M -60M -40M -20M 0 20M 40M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.2
OE margin -62.6%
Oper. margin -12.2%
Accruals 11.6%
EBITDA margin -12.0%
FCF margin -53.3%
OCF margin -53.2%
Profit margin -0.058%
ROA -0.013%
ROCE -2.9%
ROE -0.014%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.0
RPO / sales 0.23×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Cash runway 8.3 yr
Current ratio 45.9×
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 14.0×
F-score 3.9 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

8.7
Sales CAGR 4Y +84.4%
Sales/sh Y/Y +35.7%
Shares change +86.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.